GlassScriptPhysician profile
Parul Gupta
NPI 1023001187
$791.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2021: $50.62 · 2022: $63.77 · 2023: $377 · 2024: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $178.53 | 2023-2024 | Veozah |
| Abbvie INC. | $161.77 | 2019-2024 | |
| Hologic Sales and Service, LLC | $67.76 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $47.86 | 2019-2023 | Paragard T 380a |
| Avion Pharmaceuticals | $45.49 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.14 | 2022-2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $37.01 | 2024 | Slynd |
| Vertical Pharmaceuticals, LLC | $28.55 | 2019 | |
| Mayne Pharma Commercial LLC | $26.89 | 2024 | |
| Organon LLC | $24.88 | 2023 | Nexplanon |
| Biogen, INC. | $24.43 | 2024 | Zurzuvae |
| Therapeuticsmd, INC. | $23.18 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.70 | 2019 | |
| Shield Therapeutics INC | $18.39 | 2023 | Accrufer |
| Mission Pharmacal Company | $16.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.33 | 2019 | |
| Ascend Therapeutics US, LLC | $14.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.